Literature DB >> 26651253

Changing epidemiology of hepatocellular carcinoma in Asia.

George Boon-Bee Goh1, Pik-Eu Chang2, Chee-Kiat Tan3.   

Abstract

Hepatocellular carcinoma is a major problem in Asia because of the presence of multiple risk factors in the region such as endemicity of hepatitis B and significant contamination of foodstuff by aflatoxin in some areas. Another risk factor for HCC, chronic hepatitis C infection, in Asia is most significant in Japan, the only Asian country with more HCV than HBV-related hepatocellular carcinoma. As these risk factors can and are being modified by measures such as universal hepatitis B immunisation, successful treatment of HCV infections, reduction and improved surveillance of aflatoxin contamination of foodstuff, it is not surprising that the epidemiology of HCC in Asia is changing. All these are offset by the rising importance of NAFLD and NASH as chronic liver diseases and risk factors for HCC which contributes to the changing epidemiology of HCC in Asia.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aflatoxin; Epidemiology; Hepatitis B; Hepatitis C; Hepatocellular carcinoma; Non-alcoholic steatohepatitis NASH

Mesh:

Substances:

Year:  2015        PMID: 26651253     DOI: 10.1016/j.bpg.2015.09.007

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  53 in total

Review 1.  Global Epidemiology of Hepatocellular Carcinoma (HCC Epidemiology).

Authors:  Aysegul Ozakyol
Journal:  J Gastrointest Cancer       Date:  2017-09

2.  NAFLD-which patients should have hepatocellular carcinoma surveillance?

Authors:  Zeynep C Elcioglu; Helen L Reeves
Journal:  Hepatobiliary Surg Nutr       Date:  2017-10       Impact factor: 7.293

3.  [High-performance liquid chromatography-mass spectrometry-based serum metabolic profiling in patients with HBV-related hepatocellular carcinoma].

Authors:  Lei Zhang; Zhijuan Fan; Hua Kang; Yufan Wang; Shuye Liu; Zhongqiang Shan
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-01-30

4.  Liver Resection for Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: a Multicenter Propensity Matching Analysis with HBV-HCC.

Authors:  Tian Yang; Lun-Yang Hu; Zhen-Li Li; Kai Liu; Han Wu; Hao Xing; Wan Yee Lau; Timothy M Pawlik; Yong-Yi Zeng; Ya-Hao Zhou; Wei-Min Gu; Hong Wang; Ting-Hao Chen; Jun Han; Chao Li; Ming-Da Wang; Meng-Chao Wu; Feng Shen
Journal:  J Gastrointest Surg       Date:  2019-01-07       Impact factor: 3.452

5.  Comparison of Hepatocellular Carcinoma in Patients with Cryptogenic Versus Hepatitis B Etiology: A Study of 1079 Cases Over 3 Decades.

Authors:  Zhong-Hong Liew; George Boon-Bee Goh; Ying Hao; Pik-Eu Chang; Chee-Kiat Tan
Journal:  Dig Dis Sci       Date:  2018-10-16       Impact factor: 3.199

Review 6.  Prevention of Hepatocellular Carcinoma.

Authors:  Kerstin Schütte; Fathi Balbisi; Peter Malfertheiner
Journal:  Gastrointest Tumors       Date:  2016-08-18

7.  Pre- and Postoperative Models for Prediction of Recurrence in Non-B, Non-C Hepatocellular Carcinoma.

Authors:  Kongying Lin; Qizhen Huang; Lei Wang; Jianxing Zeng; Zongren Ding; Hongzhi Liu; Jun Fu; Pengfei Guo; Zhenwei Chen; Yongyi Zeng; Weiping Zhou; Jingfeng Liu
Journal:  Front Oncol       Date:  2021-02-18       Impact factor: 6.244

8.  Validation of a Simple Scoring System to Predict Sorafenib Effectiveness in Patients with Hepatocellular Carcinoma.

Authors:  Giovan Giuseppe Di Costanzo; Andrea Casadei Gardini; Giorgia Marisi; Francesco Giuseppe Foschi; Mario Scartozzi; Rocco Granata; Luca Faloppi; Stefano Cascinu; Nicola Silvestris; Oronzo Brunetti; Vincenzo Ostilio Palmieri; Giorgio Ercolani; Raffaella Tortora
Journal:  Target Oncol       Date:  2017-12       Impact factor: 4.864

9.  Prognostic value of p53 mutation for poor outcome of Asian primary liver cancer patients: evidence from a cohort study and meta-analysis of 988 patients.

Authors:  Xiajie Wen; Fengmin Lu; Shuang Liu
Journal:  Onco Targets Ther       Date:  2016-12-08       Impact factor: 4.147

10.  Trends and Age-Period-Cohort Effects on the Prevalence, Incidence and Mortality of Hepatocellular Carcinoma from 2008 to 2017 in Tianjin, China.

Authors:  Chengyu Liu; Jing Wu; Zheng Chang
Journal:  Int J Environ Res Public Health       Date:  2021-06-04       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.